Tag: India
Govt coming up with pharma research policy to uplift Industry-academia linkages:...
Government is coming up with certain initiatives like Pharma research policy to uplift Industry-academia linkages to magnify research in this area which will bring immediate solutions to the problems," said Dr. Mansukh Mandaviya at the Pharma Med HD conference held by PHDCCI
SyntheticMR announces new subsidiary in India
The SyntheticMR India subsidiary employs more than 10 people across India and supports a user base of over 20 institutions
Agilent to host its first ‘Future Lab Summit’ in Ahmedabad this...
The summit will showcase an array of Agilent’s future-ready analytical solutions
Avantor named best company for upstream processing & single-use solutions at...
Awards recognize Avantor innovations that allow the biopharmaceutical industry to bring therapies to market more efficiently
National Doctors’ Day: Medical fraternity gained first-hand experience during pandemic
Leading doctors share their experiences and learnings from the pandemic
NHA to host Hackathon Series under Ayushman Bharat Digital Mission
Slated to be held from 14th to 17th July 2022, the hackathon is being organized with the aim to build innovative solutions for healthcare service delivery using UHI. Winners stand to win exciting cash prizes
Elimination of Malaria in India needs active participation from private sector
The road to elimination demands a concerted and a much more aggressive strategy towards addressing key gaps and challenges
Experts recommend a comprehensive care model for tackling Sickle cell disease
India is estimated to have the second-highest burden of SCD after Nigeria- it is being estimated that there may be 18 million SCT and 1.4 million SCD patients among the tribal population
Stem cell transplant only curative treatment for Sickle cell Disease: Experts
About 20 percent of children with sickle disease died by the age of two, and 30 percent children with Sickle Cell Disease die before they reach adulthood
Expert panel in favor of approval to Serum Institute’s cervical cancer...
With the government panel's backing, Serum Institute of India's Quadrivalent Human Papillomavirus vaccine (qHPV) is expected to hit the markets soon